Relmada Therapeutics (RLMD) P/E (2014 - 2026)
Relmada Therapeutics (RLMD) P/E from Oct 9, 2014 to Jul 21, 2026. The TTM Relmada Therapeutics (RLMD) P/E is -5.03. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Relmada Therapeutics (RLMD)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.03 | +45.90% |
| 2025 | -3.45 | +1657.09% |
| 2024 | -0.20 | -82.44% |
| 2023 | -1.12 | -57.61% |
| 2022 | -2.64 | -80.93% |
| 2021 | -13.82 | -59.81% |
| 2020 | -34.39 | -40.02% |
| 2019 | -57.33 | +1184.68% |
| 2018 | -4.46 | -43.14% |
| 2017 | -7.85 | +11.16% |
| 2016 | -7.06 | -128.11% |
| 2015 | 25.11 | -193.77% |
| 2014 | -26.78 | N/A |
Comparison Relmada Therapeutics (RLMD) P/E with competitors
Relmada Therapeutics (RLMD) P/E is -5.03.